# An Open Label Study of FT218 in Subjects With Narcolepsy

> **NCT04451668** · PHASE3 · COMPLETED · sponsor: **Avadel** · enrollment: 184 (actual)

## Conditions studied

- Narcolepsy
- Cataplexy
- Excessive Daytime Somnolence
- Sleep Disorder
- Sleep Disturbance
- Sleep Wake Disorders

## Interventions

- **DRUG:** FT218

## Key facts

- **NCT ID:** NCT04451668
- **Lead sponsor:** Avadel
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-06-12
- **Primary completion:** 2023-12-22
- **Final completion:** 2024-11-18
- **Target enrollment:** 184 (ACTUAL)
- **Last updated:** 2025-10-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04451668

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04451668, "An Open Label Study of FT218 in Subjects With Narcolepsy". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT04451668. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*